A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...
Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.
The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...
The study, published in the journal Antioxidants, notes that when mice were given a stable form of carnosic acid, they showed ...
China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...
In the late 90s, when email was still a novelty for many and before the term "fake news" had even made the news, an ominous ...